Dr. Essam Hamza reports

TREATMENT.COM AI ENTERS INTO A BINDING LETTER OF INTENT TO ACQUIRE ALEA HEALTH HOLDINGS LIMITED ADDING AN AI POWERED VOICE AGENT AND MENTAL HEALTH TO ITS PLATFORM

Treatment.com AI Inc. has entered into a binding letter of intent dated Jan. 28, 2025, with Alea Health Holdings Ltd. for the proposed acquisition of Alea Health by Treatment.com. Alea Health is a United Arab Emirates (UAE) based technology company building innovative AI (artificial intelligence) solutions for both primary and mental health care.

Highlights:

• Strategic expansion with proposed acquisition of Alea Health Holdings, a UAE-based AI company;
• Proprietary voice agent using conversational AI for onboarding and triaging patients;
• Extended geographic reach -- entry into the Middle East health care market;
• Advancing mental health support using Alea's proprietary and AI-powered mental health platform to augment primary and specialist care;
• Enhanced bench strength -- expertise driving innovation.

Strategic platform expansion with Alea Health

Alea Health has developed a proprietary on-line therapy platform that leverages AI-driven tools to address mental health challenges. Its platform incorporates conversational AI and voice technology to optimize patient intake and follow-up processes, reducing administrative burdens and enhancing patient engagement.

The acquisition of Alea Health aligns with Treatment.com's mission to deliver innovative AI solutions in health care and expand its capabilities in the rapidly growing mental health and AI-driven health technology sectors.

Harnessing conversational AI for health care transformation

Treatment.com has consistently been advocating for the utilization of conversational AI in all aspects of health care delivery over the next five to 10 years. Voice AI has the opportunity to impact many aspects of the current health care systems, including:

• AI-powered and automated multilingual patient intake, triage and assessment;
• Streamlining of health care professionals' administrative tasks;
• Clinical decision support;
• Remote patient monitoring and post hospital/clinic discharge follow-ups;
• Mental health support and therapy.

The integration of Alea Health's platform with Treatment.com's proprietary Global Library of Medicine (GLM), a highly advanced and personalized AI health care engine, is aimed to enhance the company's ability to deliver a unified and comprehensive solution tailored to meet the needs of health care systems worldwide.

Extended geographic reach -- UAE

The GCC (Gulf Cooperation Council) announced at the end of 2024 that it expects to invest up to $135-billion to revolutionize health care through AI and data-driven innovation. With its presence in the UAE and an established pipeline of opportunities, Alea Health provides Treatment.com with a critical foothold in the region.

This proposed acquisition represents Treatment.com's first major investment in the Middle East, enabling the company to develop strong local relationships and tap into a market focused on modernizing health care delivery.

Advancing mental health support to augment primary care

The acquisition of Alea Health strengthens Treatment.com's focus on integrating mental health services with primary care. Treatment.com's Global Library of Medicine (GLM) currently supports over 1,000 diseases and 10,000 symptoms and risk factors, with plans to expand its mental health capabilities through 2025.

Alea Health's innovative approach combines AI and multimodal analysis, including sentiment analysis and natural language processing of voice data, to enhance therapeutic matching and predict therapeutic alliance, a key driver of successful mental health outcomes.

With a network of over 35 internationally licensed therapists, reflecting the diverse demographic segmentation of UAE residents, Alea Health's on-line therapy platform offers patients the ability to select therapists, schedule and pay for sessions, and conduct therapy on-line. The platform also includes a 24-hour-a-day/seven-day-a-week AI-powered mental health coach, providing continuous support between therapy sessions.

Enhanced bench strength -- expertise driving innovation

The entrepreneurial team behind Alea Health brings over 30 years of combined experience across AI, machine learning, SaaS (software as a service), cloud services and data science-critical components for successful health technology solutions.

With professional backgrounds spanning North America, Europe and the UAE, the team has extensive expertise in mental health services, telemedicine, medical devices, hospital digital strategies and patient intake software. This wealth of knowledge will further augment Treatment.com AI's capabilities in delivering innovative solutions across the health care spectrum.

The core team at Alea Health comprises the following.

Richard Dallala -- chief executive officer (CEO)

Mr. Dallala brings over a decade of experience in health care technology and strategic consulting. As CEO of Alea Health, he leads the development of AI-powered mental health solutions with a focus on value-based care. Previously, Mr. Dallala worked as a management consultant at McKinsey & Co., where he supported strategic engagements in various industries, including health care. He also contributed to mental health initiatives as a new services manager at Dialogue Technologies, Mirah Inc. and Cleveland Clinic Advisory. Mr. Dallala holds a degree in mechanical engineering from McGill University, and his leadership continues to drive innovation in the health care sector.

Saleh Paracha -- chief technology officer (CTO)

A visionary technology leader, Mr. Paracha oversees the innovation and execution of Alea Health's technology strategy. Under his leadership, the company launched an on-line therapy platform serving over 1,000 clients in its first month, integrating AI-driven chat, scheduling and video-conferencing capabilities. Mr. Paracha's prior experience includes roles at Phreesia, where he maintained and augmented a $100-million revenue-generating payment platform, and Dreamscape Labs, where he created SaaS augmented reality solutions. A graduate of the University of Waterloo with expertise in AI, SaaS and cloud computing, Mr. Paracha excels at building scalable, secure platforms and fostering high-performing teams.

Marco Bertetti -- chief data officer (CDO) and chief operating officer (COO)

Mr. Bertetti is a seasoned data scientist and operational strategist with a record of building impactful data products. At Alea Health, he manages both data strategy and operational growth. His prior roles include senior data scientist at Delivery Hero Talabat, where he optimized user incentives through machine learning, and principal data scientist at Stint, where he established company-wide experimentation frameworks. Mr. Bertetti has also led advanced analytics teams at Skyscanner, creating machine-learning-driven solutions. With academic foundations in data science and international economics from University College London and the University of Turin, Mr. Bertetti's expertise enhances Alea Health's innovation capacity while pursuing his PhD in natural language processing.

Dr. Essam Hamza, CEO of Treatment.com AI, commented: "We are excited to welcome the Alea Health team to Treatment.com AI. They bring with them not just a unique set of skills and experience, but also an incredible proprietary platform that we have already started incorporating into the Treatment.com AI software. The ability to have a virtual GLM-powered AI nurse call/take calls from patients, understand different languages, take a detailed smart history and help triage patients appropriately to the proper provider is a potential game changer as a health care solution. We will be working on a fully integrated platform and hope to introduce the new products to the market and our customers soon."

Mr. Dallala, co-founder and CEO of Alea Health, commented: "The acquisition of Alea Health by Treatment.com AI represents a pivotal advancement in our core mission to leverage the latest AI technology to significantly impact health care access and efficiency, including mental health. By integrating our AI capabilities with the GLM library, we can extend the reach of our technology to a wider audience, creating the foundation for a deeper impact on health care outcomes."

Transaction overview

The letter of intent contemplates that Treatment.com will acquire 100 per cent of the issued and outstanding ordinary shares in the capital of Alea by making the following payments: (i) a cash payment of $15,000 (U.S.), within seven business days from the execution of the letter of intent, which has been paid as of the date hereof; (ii) a cash payment of $180,000 (U.S.) to the holder of a simple agreement for future equity note of Alea Health on the closing date of the proposed transaction; (iii) a cash payment of $120,000 (U.S.) on the closing date to the Alea shareholders, pro rata in proportion to their holdings; and (iv) the issuance of common shares in the capital of Treatment.com with a total deemed value of $100,000 (U.S.) on the closing date, with a deemed value per each consideration share to be determined, subject to the pricing requirements of the Canadian Securities Exchange. The consideration shares shall be subject to escrow and resale restrictions to be agreed upon by Treatment.com and Alea Health.

The letter of intent sets out certain terms and conditions pursuant to which the proposed transaction will be completed. The proposed transaction remains subject to certain closing conditions, including, without limitation: (a) the completion of customary due diligence; (b) the negotiation and execution of a definitive agreement; (c) the entering into of employment or consulting agreements with certain key Alea employees; and (d) the receipt of all required regulatory and third party approvals and, if applicable, the approval of the shareholders of Alea Health. There can be no guarantees that the proposed transaction will be completed as contemplated or at all.

In addition to contractual escrow, all securities issued pursuant to the proposed transaction will be issued under prospectus exemptions pursuant to National Instrument 45-106, Prospectus Exemptions, of the Canadian Securities Administrators and may be subject to an applicable statutory hold period, along with any escrow restrictions imposed under applicable securities laws.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com AI has built a comprehensive, personalized health care AI engine -- the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps health care professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting health care professionals, allows for the inclusion of disenfranchised communities.

About Alea Health Holdings Ltd.

Alea Health is a United Arab Emirates based technology start-up founded in June, 2024, after securing a preseed investment from Antler VC. Alea Health is developing multimodal analysis (for example, sentiment analysis and natural language processing) on voice data from patients and mental health providers to enhance matching. This approach focuses on predicting therapeutic alliance, one of the key indicators of successful therapeutic outcomes. Alea Health currently operates a network of more than 35 licensed therapists and offers a proprietary on-line therapy platform. This platform enables patients to select their therapist, schedule and pay for sessions on-line, and conduct therapy sessions seamlessly. Additionally, Alea Health provides an AI-based mental health coach available 24 hours a day, seven days a week to support patients between therapy sessions. Alea Health has also been developing a fully AI-powered intake process that gathers patient needs and preferences through dynamic questioning while analyzing voice data.

We seek Safe Harbor.